BitFrontier Capital Holdings, Inc. (OTCID: BFCH), doing business as UNLOCKD Inc., provided a commercialization update on its recently acquired operating subsidiary, VerdaGenix LLC d/b/a Ancient Extracts USA, highlighting encouraging early operating results. Preliminary May 2026 revenue reached approximately $22,344, a 76% increase from April 2026 revenue of approximately $12,670. The company noted that operations commenced under UNLOCKD ownership in the middle of May, meaning the reported revenue reflects only a partial month of operations under company ownership.
Additionally, on June 2, 2026, Ancient Extracts received a purchase order representing approximately $58,823 in retail product value, with an order total of approximately $29,411 under wholesale pricing terms. All financial figures are preliminary, unaudited, and subject to further review.
John P. Gorst, Chief Executive Officer of UNLOCKD, stated, "We remain in the early stages of integrating Ancient Extracts into the UNLOCKD organization, but we are encouraged by the commercial momentum we are seeing. The combination of accelerating revenue, customer demand, and expanding distribution opportunities reinforces our belief that Ancient Extracts possesses many of the qualities that originally attracted us to this acquisition."
Ancient Extracts USA offers a portfolio of functional mushroom products, ceremonial teas, cacao blends, matcha products, shilajit, and wellness-focused consumer goods under the brand philosophy of "Ancient Remedies for Modern Life." The company believes the brand is well positioned to benefit from growing consumer interest in functional mushrooms, adaptogens, and botanical wellness products.
Dr. Jordan P. Balencic, Chairman and Chief Science Officer, commented, "When we evaluated Ancient Extracts, we believed the business possessed a number of attractive characteristics, including a differentiated product portfolio, a loyal customer base, a capital-efficient operating model, and multiple pathways for future growth. The initial operating results and commercial traction we are seeing continue to reinforce our conviction in the opportunity."
Separately, UNLOCKD announced that its UNLOCKD Technologies division has begun preliminary planning for future consumer health technology opportunities, including early-stage evaluation of point-of-care testing concepts. These initiatives remain in conceptual stages, and the company expects to pursue dedicated financing for such initiatives.
For more information, visit www.unlockdinc.com or follow @BFCHco on X for verified company updates.
